Quinton (Ding Quan) Ng, PhD, BSc (Hon)
he/him/his
Postdoctoral AssociateDownloadHi-Res Photo
Cards
Education
PhD
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
BSc (Hon)
National University of Singapore, Pharmacy (2019)
National University of Singapore, Pharmacy (2019)
Publications Overview
- 50 Publications
- 396 Citations
- 15 Yale Co-Authors
Featured Publication
Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial
Education
PhD
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
BSc (Hon)
National University of Singapore, Pharmacy (2019)
National University of Singapore, Pharmacy (2019)
Publications Overview
- 50 Publications
- 396 Citations
- 15 Yale Co-Authors
Featured Publication
Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial
Education
PhD
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
BSc (Hon)
National University of Singapore, Pharmacy (2019)
National University of Singapore, Pharmacy (2019)
Publications Overview
- 50 Publications
- 396 Citations
- 15 Yale Co-Authors
Featured Publication
Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial
About
Copy Link
Titles
Postdoctoral Associate
Biography
Quinton Ng, PhD, BScPharm(Hons), is a postdoctoral researcher on the Yale Cancer Center Decision Science Team and Goshua Lab. A pharmacist by training and a pharmacoepidemiologist, he focuses on health outcomes research with a deep commitment to ensuring equitable care across the cancer care continuum. His passion for this work is profoundly personal, stemming from his experience as a caregiver.
His doctoral research at the University of California, Irvine, which earned him the PhRMA Foundation Predoctoral Fellowship, established a novel framework for incorporating integrative oncology therapies into cancer survivorship from an evidence-, science-, and value-based perspective.
At Yale, he continues his research by developing expertise at the intersection of pharmacoepidemiology and decision science. His current work focuses on quantifying the value of new therapies and underutilized interventions in clinical oncology and hematology to inform evidence-based practice, improve patient outcomes, enhance healthcare decision making, and optimize healthcare resource allocation.
Last Updated on February 27, 2026.
Education & Training
- PhD
- University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
- BSc (Hon)
- National University of Singapore, Pharmacy (2019)
Research
Copy Link
Overview
Medical Research Interests
Administrative Claims, Healthcare; Biomarkers; Biostatistics; Cancer Survivors; Clinical Trial; Comparative Effectiveness Research; Cost-Effectiveness Analysis; Drug-Related Side Effects and Adverse Reactions; Economics, Medical; Electronic Health Records; Evidence-Based Medicine; Health Equity; Integrative Oncology; Medical Oncology; Pharmacoepidemiology; Survivorship
ORCID
0000-0002-0754-7901- View Lab Website
Goshua Lab
Research at a Glance
Yale Co-Authors
Frequent collaborators of Quinton (Ding Quan) Ng's published research.
Publications Timeline
A big-picture view of Quinton (Ding Quan) Ng's research output by year.
Research Interests
Research topics Quinton (Ding Quan) Ng is interested in exploring.
Satoko Ito, MD, PhD
George Goshua, MD, SM, FACP
Manraj Singh Sra, MBBS
Alfred Lee, MD, PhD
Amer Zeidan, MBBS, MD
Harlan Krumholz, MD, SM
50Publications
396Citations
Cancer Survivors
Biomarkers
Survivorship
Electronic Health Records
Integrative Oncology
Publications
Featured Publications
Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial
Ng D, Heshmatipour M, Trudeau J, Sridhar A, Pluimer B, Drayson O, Lavasani S, Parajuli R, Lee S, Agrawal A, Acharya M, Limoli C, Harris R, Xie L, Malik S, Chan A. Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial. Journal Of The National Cancer Institute 2026, djag096. PMID: 41926740, PMCID: PMC13285686, DOI: 10.1093/jnci/djag096.Peer-Reviewed Original ResearchAltmetricConceptsBreast cancer survivorsCancer survivorsPre-post effect sizesNeuropsychiatric symptomsRandomized Controlled TrialsPsychological distressDistressing symptomsObjective cognitionElectroacupuncturePilot trialEffect sizeDistressAcupointsCognitive impairmentNEA groupCognitive functionNeurocognitive testsSymptom severityMultiple comparisonsSurvivorsSymptomsRespondentsBreastTrialsAdverse eventsReal-world impact of acupuncture on analgesics and healthcare resource utilization in breast cancer survivors with pain
Ng D, Lee S, Lee R, Wang Y, Chan A. Real-world impact of acupuncture on analgesics and healthcare resource utilization in breast cancer survivors with pain. BMC Medicine 2024, 22: 394. PMID: 39285302, PMCID: PMC11406884, DOI: 10.1186/s12916-024-03626-2.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsBreast cancer survivorsImpact of acupunctureCancer survivorsHealthcare resource utilizationHealthcare costsAcupuncture-treated patientsHigh-utilizing patientsTotal healthcare costsShort-term opioidsCommercial health insuranceAcupuncture utilizationAcupuncture-treatedPost-acupunctureAcupuncture effectsPrevalence of opioidsMusculoskeletal painAcupunctureCancer diagnosisHealth insuranceReal-world settingsNSAID usePrescription fillsHealthcareUnited StatesResource utilizationDynamin-1 is a potential mediator in cancer-related cognitive impairment
Ng D, Hudson C, Nguyen T, Gupta S, Koh Y, Acharya M, Chan A. Dynamin-1 is a potential mediator in cancer-related cognitive impairment. Neurotherapeutics 2024, 22: e00480. PMID: 39516074, PMCID: PMC11742811, DOI: 10.1016/j.neurot.2024.e00480.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCancer-related cognitive impairmentFemale mouse modelNon-cancer controlsSpatial recognition memoryConsequences of cancer treatmentYoung adult cancerCytotoxic treatmentControl miceHippocampal CA1Cancer patientsMouse modelSynaptic activityAdult cancersCA3 subregionNeurological consequencesAnimal modelsCognitive impairmentAnimal studiesHuman studiesCancer treatmentNon-cancer participantsTherapeutic targetCancerExposure to cancerChemotherapySubstance Use Among Young Adult Survivors of Childhood Cancer With Cognitive Impairment: An Analysis of the Project Forward Cohort
Ng D, Ritt-Olson A, Freyer D, Miller K, Thomas S, Milam J, Chan A. Substance Use Among Young Adult Survivors of Childhood Cancer With Cognitive Impairment: An Analysis of the Project Forward Cohort. JCO Oncology Practice 2022, 19: e345-e354. PMID: 36508698, PMCID: PMC10022886, DOI: 10.1200/op.22.00458.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsYoung adult childhood cancer survivorsCancer-related cognitive impairmentYoung adult survivors of childhood cancerCancer-related late effectsAdult survivors of childhood cancerAdult childhood cancer survivorsLong-term follow-up clinicSurvivors of childhood cancerChildhood cancer survivorsSubstance use behaviorsYoung adult survivorsLog-binomial regressionMental health issuesSubstance useCognitive impairmentFollow-up clinicLong-term healthAssociated with reportsCancer survivorsUse behaviorsPsychological distressChildhood cancerDepressive symptomsCovariate adjustmentHealth issuesCurrent and recommended practices for evaluating adverse drug events using electronic health records: A systematic review
Ng D, Dang E, Chen L, Nguyen M, Nguyen M, Samman S, Nguyen T, Cadiz C, Nguyen L, Chan A. Current and recommended practices for evaluating adverse drug events using electronic health records: A systematic review. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2021, 4: 1457-1468. DOI: 10.1002/jac5.1524.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricConceptsElectronic health recordsAdverse drug eventsNewcastle-Ottawa ScaleHealth recordsDrug eventsSystematic reviewAbstract Electronic health recordsModified Newcastle-Ottawa ScaleEvaluate adverse drug eventsStructured EHR dataPeer-reviewed journalsMedian NOS scorePrescribing recordsRecommended practicesEHR dataMethodological qualityIntention-to-treatThematic analysisEffect modifiersDiagnosis codesData synthesisPharmacoepidemiologic researchCohort studyEnd-to-endNOS score
2026
Sociodemographic disparities and reasons for delayed healthcare among U.S. cancer survivors: an All of Us study
Ng D, Zheng Z, Jemal A, Chan A, Islami F. Sociodemographic disparities and reasons for delayed healthcare among U.S. cancer survivors: an All of Us study. Supportive Care In Cancer 2026, 34: 663. PMID: 42303910, PMCID: PMC13272612, DOI: 10.1007/s00520-026-10880-y.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsDelayed healthcareCancer survivorsHealthcare accessNon-Hispanic white survivorsU.S. cancer survivorsAdult cancer survivorsNational InstituteNational Institutes of HealthMinoritized racial/ethnic groupsWhite survivorsDelayed careSociodemographic disparitiesInstitutes of HealthSociodemographic factorsSociodemographic characteristicsRacial/ethnic groupsHigher RatesSocioeconomic factorsHealthcareFemale survivorsSurvivorsSocial needsUS studiesAffordability issuesNervousnessTrajectory and predictors of cancer- and treatment-related fatigue (CRF) in adolescent and young adult cancer patients: a prospective, longitudinal study
Chan A, Chan D, Agrawal P, Beppu L, Kober K, Ng D, Sayer M, Trudeau J. Trajectory and predictors of cancer- and treatment-related fatigue (CRF) in adolescent and young adult cancer patients: a prospective, longitudinal study. BMC Cancer 2026 PMID: 42304319, DOI: 10.1186/s12885-026-16324-4.Peer-Reviewed Original ResearchConceptsNon-cancer controlsTreatment-related fatigueSelf-reported fatigue symptomsYoung adult cancer patientsYoung adult cancerPsychological distress scoresAdult cancer patientsAssociated with fatigueNational Cancer Centre SingaporeAt-risk patientsActive chemotherapyDistress scoresSymptom burdenFatigue scoresAYACDistressing symptomsFatigue symptomsMixed-effects modelsFatigue challengeAdult cancersFemale sexMixed-effectsDebilitating symptomsLongitudinal studyClinical assessmentComparing the association between out‐of‐pocket cost burden and cost‐related care avoidance among individuals with and without a history of cancer
Liang X, Tay D, Ke Y, Ng D, Patikorn C, Asche C, Chaiyakunapruk N, Kirchhoff A, Chan R, Chan A, Tan C. Comparing the association between out‐of‐pocket cost burden and cost‐related care avoidance among individuals with and without a history of cancer. Cancer 2026, 132: e70495. PMID: 42290381, PMCID: PMC13266579, DOI: 10.1002/cncr.70495.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsCare avoidanceCancer historyCost burdenHousehold incomeOut-of-pocket cost burdenOut-of-pocket (OOP) costsHistory of cancerOOP health care expendituresMultivariate modelHealth care expendituresCross-sectional studyRetrospective cross-sectional studyFinancial toxicityHealth systemEffect modificationTargeted interventionsCare expendituresOOP costsRandom interceptRespondent characteristicsSurvey wavesAmerica StudyPatient characteristicsCareBurdenBarriers to effective first-line treatment for women with iron deficiency
Rinaldi K, Ng D, Tadepalli A, Ito S, Goshua G, Wang D. Barriers to effective first-line treatment for women with iron deficiency. Expert Review Of Hematology 2026, ahead-of-print: 1-3. PMID: 42212667, DOI: 10.1080/17474086.2026.2683026.Peer-Reviewed Original ResearchJAKPOT Prediction Rule for Erythrocytosis: External Validation and Cost‐Effectiveness Analysis
Lam B, Ito S, Ryu J, O'Sullivan K, Potnis K, Lu R, Bidikian A, Ng D, Singh R, Deter A, Carfagnini C, Bechara S, Kandula M, Do N, Fillmore N, Freed J, Patell R, La J, Goshua G. JAKPOT Prediction Rule for Erythrocytosis: External Validation and Cost‐Effectiveness Analysis. American Journal Of Hematology 2026 PMID: 42227164, DOI: 10.1002/ajh.70390.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Copy Link
Honors
honor Predoctoral Fellowship in Value Assessment and Health Outcomes Research
04/13/2023National AwardPhRMA FoundationDetailsUnited States
Links
Copy Link
Get In Touch
Copy Link
Contacts
Email
Locations
Yale Cancer Center Decision Science
Academic Office
300 George Street, Ste 900
New Haven, CT 06511
Social Media